While regulation of diagnostic tests by the Food and Drug Administration (FDA) may not directly impact the biobanking industry, it does have an impact on the development of new therapies, particularly personalized medicine, and all of us have a stake in the future of personalized medicine.
{iframe}http://blog.fisherbioservices.com/the-road-to-personalized-medicine-fdas-proposed-guidelines-on-companion-diagnostics{/iframe}